HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Expression of hypoxia-inducible angiogenic proteins (hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and E26 transformation-specific-1) and plaque hemorrhage in human carotid atherosclerosis.

AbstractOBJECT:
Plaque hemorrhage in carotid atherosclerosis promotes plaque progression, resulting in cerebrovascular disease. Hypoxia inducible factor-1alpha (HIF-1alpha) induces angiogenesis via the expression of vascular endothelial growth factor (VEGF) and E26 transformation-specific-1 (Ets-1). The authors investigated human carotid plaques to determine whether these hypoxia-inducible angiogenic proteins play a major role in intraplaque angiogenesis and hemorrhage.
METHODS:
The expression of HIF-1alpha, VEGF, and Ets-1 was analyzed using immunohistochemistry and Western blotting in 29 human carotid plaques obtained at carotid endarterectomy. The authors investigated the relationship between plaque characteristics and clinical symptoms.
RESULTS:
A higher incidence of plaque hemorrhage was observed in plaques associated with symptoms than in those without symptoms (p = 0.03). Hypoxia-inducible factor-1alpha, VEGF, and Ets-1 coexisted in the deep layer of plaque, where angiogenesis was remarkably developed; the expression levels of HIF-1alpha, VEGF, and Ets-1 were significantly enhanced in the main lesion of the plaque (p < 0.01). Symptomatic plaques showed higher expression of VEGF (p = 0.04) than asymptomatic plaques. Plaques with hemorrhage showed a higher incidence of plaque ulcer (p = 0.001) and higher expression of Ets-1 (p = 0.03) than those without hemorrhage. Moreover, significantly increased expressions of VEGF (p = 0.01) and Ets-1 (p = 0.006) were observed in plaques with not only hemorrhages but also ulcers and severe stenosis.
CONCLUSIONS:
The findings in this study suggest that hypoxia-inducible angiogenic proteins in human carotid atherosclerosis promote intraplaque angiogenesis, which can induce plaque hemorrhage and progression.
AuthorsTetsuhiro Higashida, Hiroshi Kanno, Masato Nakano, Kengo Funakoshi, Isao Yamamoto
JournalJournal of neurosurgery (J Neurosurg) Vol. 109 Issue 1 Pg. 83-91 (Jul 2008) ISSN: 0022-3085 [Print] United States
PMID18590436 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • ETS1 protein, human
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Proto-Oncogene Protein c-ets-1
  • Vascular Endothelial Growth Factor A
Topics
  • Aged
  • Atherosclerosis (complications, metabolism, pathology)
  • Carotid Artery Diseases (complications, metabolism, pathology)
  • Case-Control Studies
  • Cohort Studies
  • Female
  • Hemorrhage (etiology, metabolism, pathology)
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit (metabolism)
  • Male
  • Middle Aged
  • Neovascularization, Pathologic (complications, metabolism, pathology)
  • Proto-Oncogene Protein c-ets-1 (metabolism)
  • Vascular Endothelial Growth Factor A (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: